Inhibition of eEF2 is toxic to mammalian cells due to inhibition of translation, but here, we demonstrate that inhibition of LSG1, and possibly EFL1 by extension, may provide an effective prosenescent cancer therapy with lesser side effects since translation remains unimpaired. Here, EFL1 is linked to cancer.